skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

What is the future of peer review? Why is there fraud in science? Is plagiarism out of control? Why do scientists do bad things? Is it all a case of: “All that is necessary for the triumph of evil is that good men do nothing?”

(2503) Views  (382) Full article downloads

Authors: Chris R Triggle, David J Triggle

Published Date May 2007 Volume 2007:3(1) Pages 39 - 53
DOI: http://dx.doi.org/10.2147/VHRM.S

Chris R Triggle1, David J Triggle2

1School of Medical Sciences, RMIT University, Melbourne, Victoria, Australia; 2School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo NY, USA

Abstract: Peer review is an essential component of the process that is universally applied prior to the acceptance of a manuscript, grant or other scholarly work. Most of us willingly accept the responsibilities that come with being a reviewer but how comfortable are we with the process? Peer review is open to abuse but how should it be policed and can it be improved? A bad peer review process can inadvertently ruin an individual’s career, but are there penalties for policing a reviewer who deliberately sabotages a manuscript or grant? Science has received an increasingly tainted name because of recent high profile cases of alleged scientific misconduct. Once considered the results of work stress or a temporary mental health problem, scientific misconduct is increasingly being reported and proved to be a repeat offence. How should scientific misconduct be handled—is it a criminal offence and subject to national or international law? Similarly plagiarism is an ever-increasing concern whether at the level of the student or a university president. Are the existing laws tough enough? These issues, with appropriate examples, are dealt with in this review.

Keywords: peer review, journal impact factors, conflicts of interest, scientific misconduct, plagiarism








Readers of this article also read:

A review and critique of assessment instruments for patients with persistent pain
Fosphenytoin for the treatment of status epilepticus: an evidence-based assessment of its clinical and economic outcomes
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Levodopa in the treatment of Parkinson’s disease: an old drug still going strong
The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?
Assessment of cumulative exposure to UVA through study of asymmetric facial skin damage
Nanostructured delivery system for zinc phthalocyanine: preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells
Corrigendum
Erratum
The predictive power of depression screening procedures for veterans with coronary artery disease
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University